Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA9 | Q16790 | 3/20 | 0.40 |
| ▸ | CA12 | O43570 | 2/20 | 0.40 |
| ▸ | CA1 | P00915 | 2/20 | 0.40 |
| ▸ | CA2 | P00918 | 2/20 | 0.40 |
| ▸ | RAF1 | P04049 | 15/20 | 0.37 |
| ▸ | BRAF | P15056 | 15/20 | 0.37 |
| ▸ | JAK2 | O60674 | 1/20 | 0.36 |
| ▸ | JAK1 | P23458 | 1/20 | 0.36 |
| ▸ | TYK2 | P29597 | 1/20 | 0.36 |
| ▸ | JAK3 | P52333 | 1/20 | 0.36 |
| ▸ | MTOR | P42345 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27263074 | 1.00 | CA9 (0.40) | CA9CA12CA1CA2RAF1 | |
| SCHEMBL30765238 | 0.90 | MTOR (0.37) | CA9CA12CA1CA2RAF1 | |
| SCHEMBL27263073 | 0.90 | MTOR (0.37) | CA9CA12CA1CA2RAF1 | |
| SCHEMBL30765407 | 0.88 | TGFBR1 (0.42) | RAF1BRAFJAK2JAK1TYK2 | |
| SCHEMBL27262365 | 0.88 | TGFBR1 (0.42) | RAF1BRAFJAK2JAK1TYK2 | |
| SCHEMBL27262872 | 0.82 | MAPT (0.43) | JAK2JAK1TYK2JAK3 | |
| SCHEMBL30765215 | 0.82 | MAPT (0.43) | JAK2JAK1TYK2JAK3 | |
| SCHEMBL30765278 | 0.80 | CYP3A4 (0.39) | RAF1BRAF | |
| SCHEMBL27263071 | 0.80 | CYP3A4 (0.39) | RAF1BRAF | |
| SCHEMBL27262543 | 0.78 | TGFBR1 (0.40) | JAK2JAK1TYK2JAK3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024033280-A1 | FUROPYRIDIN AND FUROPYRIMIDIN, INHIBITORS OF PI4K, FOR USE IN THE TREATMENT OF PARASITE INFECTION AND MALARIA | MERCK PATENT GMBH (DE) | 2024-02-15 | — | — | WO | disclosed |